This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jun;28(6):561-2.

doi: 10.1038/nbt0610-561.

Raising the bar for cancer therapy models

Giulio Francia, Robert S Kerbel

PMID: 20531333
DOI: 10.1038/nbt0610-561

Comment

Raising the bar for cancer therapy models

Giulio Francia et al. Nat Biotechnol. 2010 Jun.

. 2010 Jun;28(6):561-2.

doi: 10.1038/nbt0610-561.

Authors

Giulio Francia, Robert S Kerbel

PMID: 20531333
DOI: 10.1038/nbt0610-561

No abstract available

PubMed Disclaimer

Comment on

Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.
Singh M, Lima A, Molina R, Hamilton P, Clermont AC, Devasthali V, Thompson JD, Cheng JH, Bou Reslan H, Ho CC, Cao TC, Lee CV, Nannini MA, Fuh G, Carano RA, Koeppen H, Yu RX, Forrest WF, Plowman GD, Johnson L. Singh M, et al. Nat Biotechnol. 2010 Jun;28(6):585-93. doi: 10.1038/nbt.1640. Epub 2010 May 23. Nat Biotechnol. 2010. PMID: 20495549

Similar articles

Clinical trials in cancer.
Green JA. Green JA. Br J Cancer. 2011 May 10;104(10):1521-2. doi: 10.1038/bjc.2011.137. Br J Cancer. 2011. PMID: 21559023 Free PMC article. No abstract available.
Surrogate End Points and Their Validation in Oncology Clinical Trials.
Zhao F. Zhao F. J Clin Oncol. 2016 May 1;34(13):1436-7. doi: 10.1200/JCO.2016.66.4581. Epub 2016 Mar 7. J Clin Oncol. 2016. PMID: 26951314 No abstract available.
The quality of randomised controlled trials may be better than assumed.
del Giglio A, Costa LJ. del Giglio A, et al. BMJ. 2004 Jan 3;328(7430):24-5. doi: 10.1136/bmj.328.7430.24. BMJ. 2004. PMID: 14703541 Free PMC article. No abstract available.
Reported quality of randomized controlled trials of physiotherapy interventions has improved over time.
Moseley AM, Herbert RD, Maher CG, Sherrington C, Elkins MR. Moseley AM, et al. J Clin Epidemiol. 2011 Jun;64(6):594-601. doi: 10.1016/j.jclinepi.2010.08.009. Epub 2010 Dec 8. J Clin Epidemiol. 2011. PMID: 21144705 Review.
Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.
Marandino L, La Salvia A, Sonetto C, De Luca E, Pignataro D, Zichi C, Di Stefano RF, Ghisoni E, Lombardi P, Mariniello A, Reale ML, Trevisi E, Leone G, Muratori L, Marcato M, Bironzo P, Novello S, Aglietta M, Scagliotti GV, Perrone F, Di Maio M. Marandino L, et al. Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449. Ann Oncol. 2018. PMID: 30304498

See all similar articles

Cited by

Influence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy.
Sharma R, Buitrago S, Pitoniak R, Gibbs JF, Curtin L, Seshadri M, Repasky EA, Hylander BL. Sharma R, et al. Pancreas. 2014 Mar;43(2):298-305. doi: 10.1097/MPA.0000000000000099. Pancreas. 2014. PMID: 24518511 Free PMC article.
Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants.
Solomon AD, Dabral S, Brajesh RG, Day BW, Juric M, Zielonka J, Bosnjak ZJ, Pant T. Solomon AD, et al. Int J Mol Sci. 2025 Apr 23;26(9):3966. doi: 10.3390/ijms26093966. Int J Mol Sci. 2025. PMID: 40362211 Free PMC article. Review.
Strategies for improving the clinical benefit of antiangiogenic drug based therapies for breast cancer.
Kerbel RS. Kerbel RS. J Mammary Gland Biol Neoplasia. 2012 Dec;17(3-4):229-39. doi: 10.1007/s10911-012-9266-0. Epub 2012 Sep 26. J Mammary Gland Biol Neoplasia. 2012. PMID: 23011602 Review.
Animal models and conserved processes.
Greek R, Rice MJ. Greek R, et al. Theor Biol Med Model. 2012 Sep 10;9:40. doi: 10.1186/1742-4682-9-40. Theor Biol Med Model. 2012. PMID: 22963674 Free PMC article.
A Novel 4-Gene Score to Predict Survival, Distant Metastasis and Response to Neoadjuvant Therapy in Breast Cancer.
Oshi M, Katsuta E, Yan L, Ebos JML, Rashid OM, Matsuyama R, Endo I, Takabe K. Oshi M, et al. Cancers (Basel). 2020 May 2;12(5):1148. doi: 10.3390/cancers12051148. Cancers (Basel). 2020. PMID: 32370309 Free PMC article.

See all "Cited by" articles

References

1. Cancer Res. 2006 Apr 1;66(7):3386-91 - PubMed
1. Cancer Cell. 2009 Mar 3;15(3):232-9 - PubMed
1. N Engl J Med. 2006 Dec 14;355(24):2542-50 - PubMed
1. Nat Rev Drug Discov. 2004 Aug;3(8):711-5 - PubMed
1. Nat Rev Cancer. 2007 Sep;7(9):645-58 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group